NMAX vs OGN · rev $45.3M vs P/E 3.4, rev $6.40B
Newsmax, Inc. (NMAX) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Newsmax, Inc. (NMAX) is a broadcasting company listed on NYSE.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported NMAX revenue for 2025-09-30 was $45.3M. Net income was -$4.1M. Revenue was down 2.5% from 2025-06-30 to 2025-09-30. NMAX currently screens at market cap $1.01B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
NMAX currently screens at market cap $1.01B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the NMAX and OGN stock pages for the full models.
Not investment advice.